IGENICA BIOTHERAPEUTICS INC has a total of 40 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ABGENOMICS INT INC, FUSION PHARMACEUTICALS INC and SIRENAS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 4 | |
#4 | Australia | 3 | |
#5 | Singapore | 3 | |
#6 | South Africa | 3 | |
#7 | Canada | 2 | |
#8 | Hong Kong | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Mexico | 2 | |
#11 | Brazil | 1 | |
#12 | China | 1 | |
#13 | Israel | 1 | |
#14 | India | 1 | |
#15 | New Zealand | 1 | |
#16 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Heterocyclic compounds | |
#5 | Analysing materials | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Ha Edward | 20 |
#2 | Lippincott John | 17 |
#3 | Van Der Horst Edward Thein Htun | 17 |
#4 | Jackson David Y | 15 |
#5 | Kim Sun Young | 11 |
#6 | Presta Leonard G | 10 |
#7 | Zachwieja Joseph | 7 |
#8 | Theunissen Jan-Willem | 7 |
#9 | Tran Hoang | 7 |
#10 | Jackson David | 6 |
Publication | Filing date | Title |
---|---|---|
WO2016073845A1 | Anti-cd39 antibodies and uses thereof | |
EP3209334A2 | Novel antibody-drug conjugates and related compounds, compositions, and methods of use | |
WO2015161247A1 | Humanized anti-c16orf54 antibodies and methods of use thereof | |
EP3003390A2 | Anti-c10orf54 antibodies and uses thereof | |
US2016367699A1 | Novel linkers for antibody-drug conjugates and related compounds, compositions, and methods of use | |
US2014363454A1 | Antibody-Drug Conjugates, Compositions and Methods of Use |